for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

KYORIN Holdings, Inc.

4569.T

Latest Trade

1,897.00JPY

Change

5.00(+0.26%)

Volume

155,800

Today's Range

1,894.00

 - 

1,931.00

52 Week Range

1,688.00

 - 

2,754.00

As of on the Tokyo Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
1,892.00
Open
1,927.00
Volume
155,800
3M AVG Volume
4.33
Today's High
1,931.00
Today's Low
1,894.00
52 Week High
2,754.00
52 Week Low
1,688.00
Shares Out (MIL)
57.29
Market Cap (MIL)
122,561.30
Forward P/E
16.60
Dividend (Yield %)
3.95

Next Event

Q3 2020 Kyorin Holdings Inc Earnings Release

Latest Developments

More

Kyorin Holdings Inc - Director Hiromi Watanabe To Become President Effective June 21

Kyorin Holdings to retire treasury shares

Kyorin Holdings to repurchase up to 24.1 pct shares for 44.35 bln yen

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About KYORIN Holdings, Inc.

KYORIN Holdings, Inc. is a Japan-based holding company mainly engaged in the manufacturing and sales of pharmaceuticals. The Company operates through two business segments. The Pharmaceuticals segment is engaged in the manufacture, purchase and sales of pharmaceutical products, the evaluation of technologies, the inspection, analysis and negotiation of license affiliations, as well as the research of new drugs and candidate compounds. It also engages in the purchase and sales of medical promotion tools and packaging materials. The Healthcare segment is engaged in the manufacturing, sales and purchase of environmental sanitation products, general purpose medicines and skin care products.

Industry

Biotechnology & Drugs

Contact Info

15/16F, Ochanomizu Sorashiti

4-6, Kanda Surugadai

+81.3.35254700

http://www.kyorin-gr.co.jp

Executive Leadership

Minoru Hogawa

Chairman of the Board, Chairman of Subsidiary, Representative Director

Yutaka Ogihara

President, Representative Director

Yo Ito

Senior Executive Officer, Senior Director of Group Accounting & Finance

Michio Ohnota

President of Subsidiary, Director

Shigeru Ogihara

Senior Managing Director, President of Subsidiary

Key Stats

3.00 mean rating - 1 analysts
Sell
Hold
Buy
Revenue (MM, JPY)

2017

0.1K

2018

0.1K

2019

0.1K

2020(E)

0.1K
EPS (JPY)

2017

99.450

2018

89.280

2019

104.680

2020(E)

114.300
Price To Earnings (TTM)
19.85
Price To Sales (TTM)
1.10
Price To Book (MRQ)
0.91
Price To Cash Flow (TTM)
14.26
Total Debt To Equity (MRQ)
17.29
LT Debt To Equity (MRQ)
0.00
Return on Investment (TTM)
3.65
Return on Equity (TTM)
3.03

Latest News

Latest News

BRIEF-Kyorin Holdings unit signs production and marketing license agreement with vietnamese pharmaceutical company

* Says its subsidiary KYORIN Rimedio Co., Ltd. has agreed to provide a production and marketing license for generic medicine to BinhDinh Pharmaceutical and Medical Equipment JSC

BRIEF- Kyorin Holdings to set up drug unit in Tokyo

* Says it will set up a wholly owned drug unit in Tokyo, on Oct. 2

BRIEF- Kyorin Holdings unit Kyorin Pharmaceutical to buy jTAS

* Says its unit Kyorin Pharmaceutical Co Ltd will acquire 100 percent stake in jTAS Inc

BRIEF-Kyorin Holdings to integrate production function

* Says it plans to set up new production subsidiary to take over business from Noshiro plant of unit Kyorin Pharmaceutical Company, Limited and manufacture division of KYORIN Rimedio Co.,Ltd.

BRIEF-Kyorin holdings likely will see 10 percent rise in group operating profit for year ending in March 2018 - Nikkei

* Kyorin Holdings likely will see a 10 percent rise in group operating profit for the year ending in March 2018 - Nikkei

BRIEF-KYORIN Holdings unit gets license from Merck for drug KRP-114V

* Says its pharma unit receives license from US firm Merck & Co Inc for drug KRP-114V, a treatment for overactive bladder, owning exclusive rights to develop and commercialize in Asian area

BRIEF-R&I affirms KYORIN Holdings Inc's rating at "A-" and announces stable outlook -R&I

* Rating and Investment Information, Inc. (R&I) affirmed the company's rating at "A-" -R&I

BRIEF-Kyorin Holdings unit forms sales business alliance with Air Liquide Japan, Ltd.

* Says its unit formed sales business alliance with Air Liquide Japan, Ltd.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up